Linked from

The 16 pages that link to Graft-versus-host disease, each with the reason it gives.

• T cellRelated: Donor T cells can recognize recipient tissues as foreign and drive this disease.

• ImmunosuppressionRelated: Immunosuppressive treatment is used to prevent or control this donor-driven immune attack.

• Hematopoietic stem cell transplantationRelated: Donor immune cells can damage recipient organs after allogeneic transplantation.

• Major histocompatibility complexRelated: Donor T cells can react to recipient MHC differences after transplantation.

• Hematopoietic stem cellRelated: Donor-derived immune descendants of transplanted cells can cause this complication.

• Immune toleranceRelated: It shows how immune recognition of non-self can cause tissue injury when regulation fails.

• Bone-marrow transplantationRelated: Donor immune cells can recognize recipient tissues as foreign after an allogeneic transplant.

• Immunosuppressive therapyRelated: Immunosuppressive therapy can prevent or treat this donor-cell-driven injury.

• Cell therapyRelated: Donor-derived cell therapies can introduce immune cells that harm the recipient.

• CyclosporineRelated: Cyclosporine can suppress donor T cells in prevention and treatment regimens.

• Stem-cell therapyRelated: Donor-derived blood stem-cell therapies can trigger this serious immune complication.

• Immunosuppressive drugRelated: Immunosuppressive treatment can limit tissue injury from donor immune cells.

• Allogeneic cellsRelated: Allogeneic immune cells can attack the person receiving them, not only be attacked in return.